Clinical trialNCT04336215CompletedObservational

Rutgers COVID-19 Cohort Study

SponsorRutgers, The State University of New JerseyEnrollment829CoronavirusSARS-CoV-2

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Our long-term goal is to protect the health care workforce (HCW) caring for SARS-CoV-2-infected patients, their families, communities, and the general population. Our specific objective is to rapidly establish a prospective cohort to characterize the factors related to viral transmission and disease severity in a large healthcare system. We addressed this hypothesis by recruiting and longitudinally following 546 HCW and a comparison group of 283 non-HCW within a large academic health system, Rutgers Biomedical and Health Sciences (RBHS). By intensively following participants over a several year period (2020-2024) and collecting serial biospecimens (nasopharyngeal/throat swabs, blood, and saliva) and questionnaire data at multiple time points, we will uniquely characterize SARS-CoV-2 transmission and risk factors for COVID-19 among HCW and our larger academic community.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jeffrey L Carson, MD
Rutgers Biomedical Health Sciences
Principal Investigator
clinicaltrials.gov ↗
Reynold A Panettieri, MD
Rutgers Institute for Translational Medicine and Science
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Clinical Research Center Rutgers-Robert Wood Johnson Medical School Rwjuh East Tower -
New Brunswick, New Jersey, United States
Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
Clinical Research Unit Rutgers New Jersey Medical School
Newark, New Jersey, United States
Rutgers School of Dental Medicine
Newark, New Jersey, United States
University Hospital
Newark, New Jersey, United States
Environmental and Occupational Health Sciences Institute
Piscataway, New Jersey, United States
Rucdr Infinite Biologics
Piscataway, New Jersey, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Apr 2020
Primary completion: 31 Aug 2024
Completion: 31 Aug 2024
Last update posted: 15 May 2026
Registered enrollment: 829
Registry id: NCT04336215

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.